Insiders Plus Therapeutics, Inc.

Equities

PSTV

US72941H5090

Market Closed - Nasdaq Other stock markets 21:00:00 15/05/2024 BST			5-day change	1st Jan Change
2.32 ^USD	+6.91%		+2.20%	+32.56%

05-09	Transcript : Plus Therapeutics, Inc. - Special Call
05-09	Plus Therapeutics, Inc. announced that it has received $7.262078 million in funding from Aigh Capital Management, LLC	CI

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Plus Therapeutics, Inc. Appoints Pius Maliakal as Vice President of Clinical Operations	27/07/23	CI
Plus Therapeutics, Inc. Announces Selection of Rhenium Obisbemeda as International Non-Proprietary Name for 186RNL	26/10/22	CI
Plus Therapeutics, Inc. Announces Executive Changes	13/09/21	CI
Plus Therapeutics Announces Formation of Scientific Advisory Board	05/11/20	CI
Plus Therapeutics, Inc. Announces Brain Cancer Clinical Advisory Team	02/10/20	CI
Plus Therapeutics, Inc. Appoints Gregory Stein as Senior Vice President of Clinical Development	01/04/20	CI
Plus Therapeutics, Inc. Announces Executive Changes, Effective April 1, 2020	12/03/20	CI
Plus Therapeutics, Inc Announces Executive Changes	06/02/20	CI
Plus Therapeutics, Inc Changes to Its Board of Directors	06/02/20	CI
Plus Therapeutics Appoints Dr. An van Es-Johansson to Board of Directors	02/01/20	CI
Plus Therapeutics, Inc. Announces the Resignation of Ronald A. Martell as Member of the Board of Directors, Effective December 21, 2019	27/11/19	CI
Plus Therapeutics Appoints Desiree Smith as Corporate Controller and Principal Financial and Accounting Officer	08/11/19	CI
Plus Therapeutics, Inc. Announces Management Changes	09/08/19	CI
Cytori Therapeutics, Inc. has Changed its Name to Plus Therapeutics, Inc	29/07/19	CI
Cytori Therapeutics, Inc. Announces Executive Changes	05/07/19	CI
Cytori Therapeutics, Inc. Announces Management Changes	18/03/19	CI
Cytori Therapeutics, Inc. Announces Resignation of Gary Lyons as Member of the Board of Directors	01/02/19	CI
Cytori Therapeutics, Inc. Announces Resignation of John D. Harris as Vice President and General Manager of Cell Therapy	09/02/18	CI
Cytori Therapeutics, Inc. Announces Board Changes	29/01/18	CI
Cytori Therapeutics, Inc. Appoints Gregg Lapointe as an Independent Director	03/04/17	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Plus Therapeutics, Inc.

Equities

PSTV

US72941H5090

Insiders

Filters